Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI

Fig. 3

Whole blood NAD+ levels in patients with AKI treated with NRPT or placebo. a Percent change in whole blood NAD+ levels at 48 h as compared to 0 h. b Whole blood NAD+ levels in all Steps combined as compared to placebo. Data is shown as mean and SEM

Back to article page